أرسل هذا في رسالة قصيرة: Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore

 _    _      ___      _____     _____   __    __  
| \  / ||   / _ \\   |__  //   |  ___|| \ \\ / // 
|  \/  ||  / //\ \\    / //    | ||__    \ \/ //  
| .  . || |  ___  ||  / //__   | ||__     \  //   
|_|\/|_|| |_||  |_|| /_____||  |_____||    \//    
`-`  `-`  `-`   `-`  `-----`   `-----`      `